Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis (OXAD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kari Christine Nadeau, Stanford University
ClinicalTrials.gov Identifier:
NCT01678092
First received: August 30, 2012
Last updated: November 24, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):